case_images: PMC10315905_01
case_images: Glycemic monitoring in the high-risk newborn.
case_images: fped-11-1162226-g001.jpg
case_images: PMC10315905_01_fped-11-1162226-g001.jpg
case_images: F1
case_images: Evolution of protein and carbohydrate requirements in the first 30 days of life and enteral feeding started on day 5 of life.
case_images: fped-11-1162226-g002.jpg
case_images: PMC10315905_01_fped-11-1162226-g002.jpg
case_images: F2
case_images: On days 24-25 of life, the newborn presented with clinical lethargy, hypotonia, cyanosis with increased ventilation parameters, feeding difficulties, and paraclinical blood glucose 22 mg/dl, persistent hypoglycemia that does not resolve with glucose bolus administration and supplementation in perfusion requiring increased glucose intake of 16 g/kg/day (Figure 2), and hydrocortisone hemisuccinate was added to the treatment (used as part of therapy) to maintain normal glycemia, for which a congenital metabolic disease is suspected.
case_images: Preterm weight curve: slow ascent with a weight loss of 12% corresponding to the age, followed by stagnation on days 23-25 with decreased digestive tolerance, and then with a favorable evolution.
case_images: fped-11-1162226-g003.jpg
case_images: PMC10315905_01_fped-11-1162226-g003.jpg
case_images: F3
case_images: Being a premature newborn with intrauterine growth restriction and hemodynamic instability, enteral feeding was temporarily postponed in the first 5 days of life (exclusively parenteral nutrition), and later fed with a hydrolyzed milk formula by discontinuous gavage in small quantities due to poor digestive tolerance, with a slow weight gain curve (Figure 3).